$ITMN Recent Headlines Deal lifts Roche; Draghi boosts

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$ITMN Recent Headlines

Deal lifts Roche; Draghi boosts banks: Europe’s stock moves 46 min ago - Barbara Kollmeyer
S&P 500 jumps above 2,000 for intraday record 57 min ago - Victor Reklaitis
Burger King soars, Regardo Biosciences plummets, Apple on track for record 10:08 a.m. Today - Angela Johnson
InterMune shares soar 36% after merger deal with Roche 9:31 a.m. Today - Tomi Kilgore
InterMune shares surge 37% premarket after Roche buyout offer 7:08 a.m. Today - Tomi Kilgore
Roche to buy InterMune for $8.3 billion 10:42 p.m. Aug. 24, 2014 - Jonathan D. Rockoff
Six stocks to watch 9:15 a.m. Aug. 21, 2014 - The Trading Deck
Charting an uneven recovery attempt 10:57 a.m. Aug. 15, 2014 - Michael Ashbaugh
6 stocks to watch 3:25 p.m. May 29, 2014 - The Trading Deck
Charting the Nasdaq’s technical breakout 12:34 p.m. May 27, 2014 - Michael Ashbaugh
Charting the Nasdaq’s technical breakout 12:05 p.m. May 27, 2014 - Michael Ashbaugh
6 stocks to watch 3:25 p.m. May 7, 2014 - The Trading Deck
InterMune slips off lofty perch while Aegerion's earnings disappoint 12:26 p.m. Feb. 26, 2014 - Russ Britt
'Bad' weather heads west, retailers report, and don't short addiction 8:06 a.m. Feb. 26, 2014 - Shawn Langlois
InterMune's big day lifts ETF, biotech index to record highs 5:44 p.m. Feb. 25, 2014 - Russ Britt
InterMune shares more than double on tests for lung-disease treatment 12:27 p.m. Feb. 25, 2014 - Russ Britt
Biogen, InterMune, Alkermes all make stock waves with earnings 2:28 p.m. July 25, 2013 - Russ Britt
Hedge funds are buying these stocks 4:41 p.m. April 26, 2013 - Insider Monkey
Market post-mortem: Big biotechs spike as Street warming to firms 5:43 p.m. April 12, 2013 - Russ Britt
InterMune shares jump after U.K. regulator recommends key drug 10:44 a.m. March 21, 2013 - Russ Britt


Roche to Acquire InterMune and Deliver Hope to Patients Worldwide 57 min ago - GuruFocus.com
On Burger King, Roche, Yellen and Draghi - Ahead of Wall Street 57 min ago - Zacks.com
Benzinga's Top Downgrades 8:11 a.m. Today - benzinga.com
Top Analyst Upgrades and Downgrades: Foot Locker, CBOE, InterMune, US Steel and More 7:42 a.m. Today - 247WallSt.com
Wall Street Breakfast: Burger King In Talks To Buy Tim Hortons 6:31 a.m. Today - Seeking Alpha
Stifel Nicolaus Downgrades InterMune To Hold 6:08 a.m. Today - benzinga.com
Roche to buy InterMune for $8.3B in cash 5:31 p.m. Aug. 24, 2014 - Seeking Alpha
Roche to Acquire Biotech Firm 12:00 p.m. Aug. 24, 2014 - The Wall Street Journal Interactive Edition
Will This Analyst Downgrade Hurt InterMune (ITMN) Stock Today? 9:25 a.m. Aug. 21, 2014 - TheStreet.com
Top Analyst Upgrades and Downgrades: HP, InterMune, MeetMe, Tesla and More 8:08 a.m. Aug. 21, 2014 - 247WallSt.com
How Sanofi's Growth Strategy Will Catapult Afrezza Into a Blockbuster Drug 12:43 p.m. Aug. 20, 2014 - GuruFocus.com
Today In SA PRO: Monday, August 18 5:00 a.m. Aug. 19, 2014 - Seeking Alpha
Weekly CEO Sells Highlight: Protective Life Corp, Western Refining Inc, InterMune Inc, and ... 10:30 a.m. Aug. 18, 2014 - GuruFocus.com
Wall Street Breakfast: Eurozone Banks To Borrow €250B From ECB 6:31 a.m. Aug. 18, 2014 - Seeking Alpha
Place a Bet on Potential Takeover Target InterMune 8:18 p.m. Aug. 17, 2014 - InvestorPlace.com
Stock Market News for August 14, 2014 - Market News 10:10 a.m. Aug. 14, 2014 - Zacks.com
InterMune (ITMN) Is Today's Perilous Reversal Stock 9:58 a.m. Aug. 14, 2014 - TheStreet.com
InterMune (ITMN) Jumps: Stock Adds 14.4% in Session - Tale of the Tape 8:51 a.m. Aug. 14, 2014 - Zacks.com
Benzinga's Top Downgrades 8:23 a.m. Aug. 14, 2014 - benzinga.com
Top Analyst Upgrades and Downgrades: Cisco, Exxon, Ford, GM, InterMune, Tesla, Twitter and More 8:20 a.m. Aug. 14, 2014 - 247WallSt.com


INTERMUNE, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 49 min ago - PR Newswire - PRF
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of InterMune, Inc. 9:28 a.m. Today - PR Newswire - PRF
INTERMUNE SHAREHOLDER ALERT - Andrews & Springer LLC Is Seeking More Cash for Shareholders of Intermune, Inc. - ITMN 8:06 a.m. Today - BusinessWire - BZX
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of InterMune, Inc. Stockholders 6:56 p.m. Aug. 24, 2014 - BusinessWire - BZX
Block & Leviton LLP Investigates InterMune, Inc. for Possible Breaches of Fiduciary Duty in Connection with Its Merger with Roche 3:49 p.m. Aug. 24, 2014 - PR Newswire - PRF
Roche and InterMune Reach Definitive Merger Agreement 12:00 p.m. Aug. 24, 2014 - PR Newswire - PRF
Critical Alerts For Kate Spade & Co, Canadian Solar, Jazz Pharmaceuticals, InterMune and Micron. Released By InvestorsObserver 9:31 a.m. Aug. 14, 2014 - PR Newswire - PRF
Upcoming Conferences, Quarterly Earnings Releases, Market Activity, and Plant Updates - Research Reports on Intuitive Surgical, InterMune, Precision Castparts, Exelon and Duke Energy 8:00 a.m. Aug. 14, 2014 - PR Newswire - PRF
Biotech Equities Technical Momentum -- InterMune, Biogen Idec, Insmed, Dendreon, and Alexion Pharma 8:40 a.m. Aug. 11, 2014 - PR Newswire - PRF
Critical Alerts For Medidata Solutions, Netflix, Weyerhaeuser, InterMune, and Avago Technologies Released By InvestorsObserver 9:31 a.m. July 30, 2014 - PR Newswire - PRF
Financial Results, Clinical Trial Initiations, Drug Designations, Appointments, and Study Results - Research Reports on Cubist, Jazz, InterMune, NPS Pharmaceuticals and ACADIA 9:00 a.m. July 30, 2014 - PR Newswire - PRF
InterMune to Release Second Quarter Financial Results on August 6 8:00 a.m. July 28, 2014 - PR Newswire - PRF
SEC Filings, Positive Trial Results, Technical Updates, and sNDA Updates - Analyst Notes on Questcor, Exelixis, InterMune, Progenics and Arrowhead 8:40 a.m. July 18, 2014 - PR Newswire - PRF
InterMune Receives FDA Breakthough Therapy Designation For Pirfenidone, An Investigational Treatment For IPF 12:38 p.m. July 17, 2014 - PR Newswire - PRF
Biotech Equities under the Scanner -- Research on Alexion Pharma, InterMune, Cytokinetics, and Biogen Idec 5:55 a.m. July 7, 2014 - PR Newswire - PRF
Critical Alerts For Micron, InterMune, McDonald's, Visa, and NVIDIA Released By InvestorsObserver 9:31 a.m. June 25, 2014 - PR Newswire - PRF
NDA Resubmission, Clinical Data and Findings, and Conference Participations - Analyst Notes on InterMune, ResMed, Seattle Genetics, Insulet and Charles River 6:30 a.m. June 5, 2014 - PR Newswire - PRF
Critical Alerts For Macy's, Western Digital, InterMune, Merck, and Time Warner Released By InvestorsObserver 9:31 a.m. May 28, 2014 - PR Newswire - PRF
InterMune Announces Resubmission Of NDA For Pirfenidone For The Treatment Of Patients With IPF 7:00 a.m. May 27, 2014 - PR Newswire - PRF
Study Results, Extension of Supply Agreements, Drug Designations, Senior Level Appointments, and Upcoming Events - Analyst Notes on InterMune, Actavis, Bristol-Myers, AbbVie and Illumina 8:30 a.m. May 22, 2014 - PR Newswire - PRF

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Chicken Salad Chick's Utah Expansion: The Next Course

Updated Category News Views 209

A New Serving in Spanish Fork Chicken Salad Chick is taking another bite out of the Utah market with the opening of its second location in Spanish Fork. On deck for a November 17 debut, this fast-casual chain is serving up not just chicken salad, but a hefty dose of Southern hospitality and promotional giveaways to boot. The big hook? Be among the first 100 patrons and...

Continue Reading
Good Springs Earns Spot on Inc.'s 2026 Founder List

Updated Category News Views 31

There's a badge of honor in the investment world that's not about the dollars and cents pouring in—it's about having founders trust you to take care of their business babies. Good Springs Capital just snagged one by being named to Inc.'s 2026 Founder-Friendly Investors list. Now, if you're thinking this is just some fancy accolade, let's chew over the real nuggets here....

Continue Reading
Bird-X Welcomes Doolittle to Elevate Sales Strategy

Updated Category News Views 105

Change in Flight: Bird-X Eyes Strategic Growth Well, here's one that might spread its wings wide. Emanuel Doolittle has joined Bird-X, Inc. as Director of Sales and Business Development. Now, let's not beat around the bush — Bird-X isn't a name you'd see thrown around daily stock talks, but it's stirring up interest in the pest control sector without question. Why...

Continue Reading
Hagerty Amplifies Profit Forecast Amid Premium Gains

Updated Category News Views 0

An Unyielding Growth Trajectory Hagerty, Inc. just unveiled its behemoth third quarter results for 2026 and they're nothing if not eye-popping. With a whopping 18% increase in written premium year-over-year to a towering $1,099 million, there's no mistaking Hagerty’s robust growth trajectory. And that's just one piece of the puzzle—earned premiums rocketed up by 42%...

Continue Reading
Wet Noses Innovates Human-Grade Pet Food at PLMA 2026

Updated Category News Views 115

Pet Food Revolution? Wet Noses Takes the PLMA Stage Okay, listen up, pet lovers and industry folks alike—seems like Wet Noses, that Washington-based veteran in the dog treat game, is shaking up the pet food world. After cruising through the pet aisle for almost three decades, they're making a splash at the PLMA 2026. Why should we care? Well, they’re pushing this...

Continue Reading
Novartis Pulls the Plug on BioArctic Agreement

Updated Category News Views 34

Novartis Drops BioArctic Like a Hot Potato Well, folks, it looks like Novartis has decided to pack up its bags and hightail it out of its collaboration with BioArctic AB. This ain't just any small piece of news—it's got ramifications that have folks in the biotech and healthcare sector scratching their heads and, probably, feeling a mixture of apprehension and...

Continue Reading
Truecaller's Strategic Shift: Recovery and Growth in 2026

Updated Category News Views 61

Grappling with Numbers: Truecaller's Q3 2026 Results A glance at Truecaller's latest report tells us they're banking on a strategic recovery.AOver their recent interim report covering January to September 2026, they disclose a modest 1% decrease in net sales reaching SEK 464 million. Now, if you scoop away the currency fluctuations, net sales climb by a soft 3% from Q2....

Continue Reading
Illumina's Role in Singapore's Precision Medicine Leap

Updated Category News Views 99

Singapore's Bold Step into Precision Medicine When it comes to revolutionizing healthcare, Singapore isn't content to sit on the sidelines. They've just thrown a serious hat into the ring with the SG-INSIGHT study, a cornerstone of their National Precision Medicine programme. And Illumina, Inc. (NASDAQ:ILMN) is right there in it, gearing up to sequence the genomes of...

Continue Reading
Elron Ventures Revamps Leadership to Boost Tech Focus

Updated Category News Views 7

Shaking Up the Leadership Roster The folks over at Elron Ventures are making some big moves, shifting the chess pieces on their leadership board in a bid to bolster their investment and M&A strategy. They're bringing in fresh blood and seasoned vets alike to navigate the rocky waters of Defense Tech, Deep Tech, Cybersecurity, and AI. You reckon they're onto something,...

Continue Reading
Restorative Getaways Aid Grieving Families, Offers Relief

Updated Category News Views 71

Finding Solace in Change: The Power of Stepping Away Grieving a lost child. It’s a trip to hell and back, and for many families, the journey feels endless. The press of everyday life—bills, jobs, commutes—offers no mercy. At times, stepping out of the blur might be the prime move toward healing, and that's where restorative getaways step in. Escaping the Everyday...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights from Q1 2025 Insurance Labor Market Webinar

Updated Category News Views 126

Insights from Q1 2025 Insurance Labor Market Webinar Chicago has become a hub for discussions about the future of the insurance industry, especially with the forthcoming webinar highlighting the results of the Q1 2025 Insurance Labor Market Study. This semi-annual study, spearheaded by The Jacobson Group, a notable leader in providing talent within the insurance sector,...

Continue Reading
Essity's Q2 2025 Report: Challenges and Growth Ambitions

Updated Category News Views 551

Organic Growth Amid Economic Challenges Essity's recent quarterly report underscores the company's resilience in the face of a tough economic landscape. Highlighting an organic sales growth of 1.9%, the company's diverse portfolio of hygiene and health products is proving to be a strong foundation during uncertain times. Quarterly Performance Overview The report for the...

Continue Reading
Equifax's Strong 2025 Q2 Performance: Revenue Growth Highlights

Updated Category News Views 508

Equifax Reports Impressive Q2 Financial Results Equifax Inc. (NYSE: EFX) recently delivered its financial outcomes for the latest quarter, demonstrating remarkable performance despite challenging market conditions. The company reported an impressive revenue of $1.537 billion for the second quarter of 2025, reflecting a notable growth rate of 7% on a reported basis and 8%...

Continue Reading
JetBlue Airways Faces Wider Loss but CEO Confident in Recovery

Updated Category News Views 260

JetBlue Airways Reports Wider Loss JetBlue Airways Corp. (NASDAQ: JBLU) announced a net loss of $143 million, translating to a loss of 39 cents per diluted share. This is a significant drop from last year's loss of $60 million, or 17 cents per share, indicating challenges in the current operational climate. Adjusted Earnings and Revenue Performance Despite the reported...

Continue Reading
Investors Urged to Act: Deadline Approaches for Nextracker Claims

Updated Category News Views 155

Understanding the Nextracker Class Action Lawsuit The recent developments regarding Nextracker Inc. have raised significant concerns among investors, particularly those who have suffered substantial financial losses. Kahn Swick & Foti, LLC (KSF), led by former Louisiana Attorney General Charles C. Foti, Jr., is urging affected shareholders to take action before the...

Continue Reading